Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul;21(7):453-456.
doi: 10.4103/ijccm.IJCCM_79_17.

Clinical Features and Outcomes of Patients with Posterior Reversible Encephalopathy Syndrome

Affiliations

Clinical Features and Outcomes of Patients with Posterior Reversible Encephalopathy Syndrome

M S Kalaiselvan et al. Indian J Crit Care Med. 2017 Jul.

Abstract

Aims: The aim of this study was to study the clinical features and outcomes of patients with posterior reversible encephalopathy syndrome (PRES) admitted to the Intensive Care Unit (ICU).

Subjects and methods: All adult patients admitted to our ICU with acute onset neurologic symptoms with focal vasogenic edema on magnetic resonance imaging (MRI) were included in the study. Data were collected on demography, coexisting illness, admission severity of illness, neurological symptoms, blood pressure, treatment initiated, and MRI findings. Outcome data collected included mortality, ICU average length of stay (ALOS), number of ventilator days, and neurological disability at discharge assessed by modified Rankin scale (MRS).

Results: Fourteen patients were admitted with PRES. Thirteen patients were female, and their mean age was 31.5 ± 8.3 years. Etiology of PRES included eclampsia (64.2%), lupus nephritis (21.4%), CKD (7.1%), and hypertension (n = 1 [7.1%]). The most common presenting symptom was seizure (92.8%), followed by visual disturbance (42.8%), headache (42.8%), encephalopathy (14.2%), and status epilepticus (14.2%). The Glasgow coma scale on admission was 12.3 ± 2.9. High blood pressure was seen in 12 patients 85.7%; their mean systolic and diastolic pressures were 173 ± 10.2 and 110 ± 8.6 mmHg, respectively. MRI showed that parieto-occipital region was most commonly involved (92.8%), followed by frontal lobe (42.8%). ICU ALOS was 4.35 ± 2.4 days and mean ventilator days was 1.7 ± 2.0 days. One patient (1/14 [7.4%]) died of multiorgan failure and 13 patients were discharged with no residual neurological deficit (MRS, 0).

Conclusions: PRES is a potentially reversible disorder with prompt recognition and control of blood pressure.

Keywords: Clinical features; critically ill; eclampsia; posterior reversible encephalopathy syndrome.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Clinical presentation of posterior reversible encephalopathy syndrome
Figure 2
Figure 2
(A1-3) Axial T2-weighted image and coronal T2-FLAIR showing hyperintensities of bilateral basal ganglia, parietal, occipital, and left temporal lobe. Diffusion-weighted images showing no restricted diffusion (patient with eclampsia). (B1-3) Axial T2-FLAIR showing hyperintensities involving bilateral frontal, parietal, temporal, and occipital lobes (postpartum eclampsia with blood pressure 180/110 mmHg)
Figure 3
Figure 3
(A1 and 2) Coronal T2-FLAIR and axial gradient-recalled echo showing abnormal signals involving bilateral parietal lobe, occipital lobe, and temporal lobe with acute intraparenchymal hemorrhage in the right temporal lobe and focal subarachnoid hemorrhage in right frontal lobe (antenatal eclampsia presented with a blood pressure of 180/120 mmHg)

References

    1. Fugate JE, Claassen DO, Cloft HJ, Kallmes DF, Kozak OS, Rabinstein AA. Posterior reversible encephalopathy syndrome: Associated clinical and radiologic findings. Mayo Clin Proc. 2010;85:427–32. - PMC - PubMed
    1. Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: Clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol. 2015;14:914–25. - PubMed
    1. Bartynski WS, Boardman JF, Zeigler ZR, Shadduck RK, Lister J. Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. AJNR Am J Neuroradiol. 2006;27:2179–90. - PMC - PubMed
    1. Furukawa M, Terae S, Chu BC, Kaneko K, Kamada H, Miyasaka K. MRI in seven cases of tacrolimus (FK-506) encephalopathy: Utility of FLAIR and diffusion-weighted imaging. Neuroradiology. 2001;43:615–21. - PubMed
    1. Kur JK, Esdaile JM. Posterior reversible encephalopathy syndrome – An underrecognized manifestation of systemic lupus erythematosus. J Rheumatol. 2006;33:2178–83. - PubMed

LinkOut - more resources